Drug intelligence / Profile preview

standardized cannabis extract in sunflower oil

Development stage
Discontinued
Lead developer
C³ Cannabinoid Compound
Modality
Small Molecules
Administration
Oral
01

Overview

CHI-921 is a standardized cannabis extract in sunflower oil developed by Canopy Growth for the treatment of insomnia. It is classified as a herbal medicine that was being investigated for its potential to improve sleep initiation and maintenance in patients with insomnia. The development program included a Phase 2 clinical trial (identified as H2017-01) that was ultimately terminated in June 2020. According to the search results, the drug's development has been discontinued, and it did not receive regulatory approval. The product was formulated as a standardized cannabis extract in sunflower oil and was administered orally.

02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GPR55 (G protein-coupled receptor 55)TRPA1 (Transient receptor potential cation channel subfamily A member 1)

Beyond the preview

Go deeper on standardized cannabis extract in sunflower oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on standardized cannabis extract in sunflower oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call